產品詳情
簡單介紹：
Anti-phospho-DOK1 (Ser450)抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-phospho-DOK1 (Ser450)抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-phospho-DOK1 (Ser450)
Cat. Number:
Anti-phospho-DOK1 (Ser450)抗體KL-13027R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Docking protein 1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. Docking protein 1 contains a putative pleckstrin Anti-phospho-DOK1 (Ser450)抗體homology domain at the amino terminus and ten PXXP SH3 recognition motifs. Docking protein 2 binds p120 (RasGAP) from CML cells. It has been postulated to play a role in mitogenic signaling.
Also known as:
DOK1 (phospho S450); DOK1 (phospho Ser450); p-DOK1 (phospho S450); docking protein 1 (downstream of tyrosine kinase 1);Anti-phospho-DOK1 (Ser450)抗體 Docking protein 1 (p62(dok)) (Downstream of tyrosine kinase 1) (pp62); docking protein 1 62kD (downstream of tyrosine kinase 1); Docking protein 1 62kD; Docking protein 1 62kD; Docking protein 1; DOK 1; DOK1; DOK-1; DOK1_HUMAN; Downstream of tyrosine kinase 1; p62(dok); P62DOK; pp62; pp62.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated Anti-phospho-DOK1 (Ser450)抗體synthesised phosphopeptide derived from human DOK1 around the phosphorylation site of Ser450.
●
Predicted Molecular Weight: 62kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-DOK1 (Ser450)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-phospho-DOK1 (Ser450)抗體
Optimal working dilutions must be determined by the end user.
